“…Although increasing reports have indicated its connection to cancer (16,29,48), DJ-1 has only been proposed as a biomarker for cancer diagnosis, prognosis, metastasis, or the sensitivity of chemotherapy. In the present study, we demonstrate that knocking down the expression of DJ-1 enhances the sensitivity of tumor cells to 4-HPR both in vitro and in vivo (Fig.…”